高级检索
    刘思旸, 张潮. EGFR-TKI术后辅助治疗价值的回顾探索[J]. 循证医学, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
    引用本文: 刘思旸, 张潮. EGFR-TKI术后辅助治疗价值的回顾探索[J]. 循证医学, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
    shu
    LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
    Citation: LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
    shu

    EGFR-TKI术后辅助治疗价值的回顾探索

    Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(1)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回